Drug Interaction Study of ALXN2050 With Fluconazole and Rifampin in Healthy Adult Participants
Status:
Recruiting
Trial end date:
2021-12-01
Target enrollment:
Participant gender:
Summary
This is a 2-part, open label, fixed-sequence study to evaluate the potential drug interaction
between ALXN2050 and fluconazole (Part 1), and between ALXN2050 and rifampin (Part 2) in
healthy adult participants. Part 1 will be a 2-period, fixed-sequence study. Part 2 will be a
single-period, fixed-sequence study.